OptiBiotix Health (LON:OPTI) Reaches New 1-Year Low – Should You Sell?

Shares of OptiBiotix Health Plc (LON:OPTIGet Free Report) hit a new 52-week low during mid-day trading on Tuesday . The stock traded as low as GBX 10.11 ($0.13) and last traded at GBX 10.65 ($0.14), with a volume of 1030047 shares. The stock had previously closed at GBX 12.75 ($0.17).

OptiBiotix Health Stock Performance

The firm has a fifty day moving average of GBX 17.90 and a 200-day moving average of GBX 19.08. The stock has a market capitalization of £11.60 million, a price-to-earnings ratio of -376.00 and a beta of 1.71. The company has a quick ratio of 7.89, a current ratio of 6.18 and a debt-to-equity ratio of 4.51.

OptiBiotix Health Company Profile

(Get Free Report)

OptiBiotix Health Plc, a life sciences company, engages in the discovery and development of microbiome modulators primarily in the United Kingdom. The company identifies and develops microbial strains, compounds, and formulations for use in food ingredients, supplements, and active compounds that impacts human physiology deriving potential health benefits.

Further Reading

Receive News & Ratings for OptiBiotix Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OptiBiotix Health and related companies with MarketBeat.com's FREE daily email newsletter.